The impact of our genes: Consequences of the apolipoprotein E polymorphism in Alzheimer disease and multiple sclerosis

详细信息    查看全文

• 作者：Franz Fazekas ; Christian Enzinger ; Stefan Ropele ; Helena Schmidt ; Reinhold Schmidt and Siegrid Strasser-Fuchs
• 关键词：Multiple sclerosis ; Apolipoprotein E polymorphism ; Alzheimer disease ; Genetics ; Magnetic resonance imaging ; Cognition
• 刊名：Journal of the Neurological Sciences
• 出版年：2006
• 出版时间：15 June 2006
• 年：2006
• 卷：245
• 期：1-2
• 页码：35-39
• 全文大小：109 K

文摘

Epidemiological studies provide strong evidence that susceptibility to multiple sclerosis (MS) is in part genetically determined. Likewise the heterogeneity in clinical manifestations, temporal course, severity, and in the pathological processes of MS are probably also influenced by our genes. Apolipoprotein E (apoE) polymorphism has been considered a candidate for impacting on MS because of its numerous functions related to brain tissue and evidence for an association with a variety of cerebral disorders, specifically Alzheimer's disease (AD). The apoE alleles ε2, ε3, and ε4 are known to impact differently on aspects such as neuronal growth and repair, neuroprotection and inflammation. After a review of the strong association of the apoE polymorphism with AD, we review the results on MS. These are far less homogenous but have gained support from morphologic and metabolic measures obtained with magnetic resonance imaging indicating a greater extent of brain destruction with the apoE ε4 allele. Evidence for a protective role of the ε2 allele in MS is weak. In view of the association with AD it is tempting to speculate that neuropsychologic functioning in MS might be even more strongly related to the apoE polymorphism and especially to the ε4 allele than other deficits, but few data on this issue are yet available. While part of the association of the apoE polymorphism with AD is supposed to be caused by apoE-isoform dependent effects on amyloid-beta deposition, no single pathogenetically relevant mechanism has yet been confirmed for MS. In summary we presently may assume only subtle effects of the apoE polymorphism on the course of MS. These effects are probably further modulated by other genes and need further investigation.